CENPQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.265580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.828000E-01
Normal-vs-Stage2
1.282570E-01
Normal-vs-Stage3
2.996300E-02
Normal-vs-Stage4
3.697400E-01
Stage1-vs-Stage2
8.768800E-01
Stage1-vs-Stage3
2.339400E-01
Stage1-vs-Stage4
7.309600E-01
Stage2-vs-Stage3
7.565900E-02
Stage2-vs-Stage4
7.153400E-01
Stage3-vs-Stage4
7.341700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.458580E-01
Normal-vs-AfricanAmerican
4.842200E-02
Normal-vs-Asian
1.080750E-01
Caucasian-vs-AfricanAmerican
4.959600E-01
Caucasian-vs-Asian
7.255000E-01
AfricanAmerican-vs-Asian
6.422600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.118390E-01
Normal-vs-Female
1.637580E-01
Male-vs-Female
8.513800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.519180E-01
Normal-vs-Age(41-60Yrs)
3.470400E-01
Normal-vs-Age(61-80Yrs)
5.646100E-02
Normal-vs-Age(81-100Yrs)
3.113400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.183400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.516000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.540200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.018320E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.248800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.072200E-02
Normal-vs-Daily Drinker
4.128200E-02
Normal-vs-Weekly Drinker
3.518200E-01
Normal-vs-Occasional Drinker
6.750800E-01
Normal-vs-Social Drinker
2.592400E-01
Non Drinker-vs-Daily Drinker
6.351800E-01
Non Drinker-vs-Weekly Drinker
4.228400E-01
Non Drinker-vs-Occasional Drinker
1.190010E-02
Non Drinker-vs-Social Drinker
1.276950E-01
Daily Drinker-vs-Weekly Drinker
5.875200E-01
Daily Drinker-vs-Occasional Drinker
2.142200E-02
Daily Drinker-vs-Social Drinker
2.843800E-01
Weekly Drinker-vs-Occasional Drinker
2.651000E-01
Weekly Drinker-vs-Social Drinker
8.420800E-01
Occasional Drinker-vs-Social Drinker
2.750800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.245000E-01
Normal-vs-Grade 2
7.444600E-01
Normal-vs-Grade 3
7.731200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.932400E-01
Grade 1-vs-Grade 3
2.225600E-01
Grade 1-vs-Grade 4
7.245000E-01
Grade 2-vs-Grade 3
3.470000E-01
Grade 2-vs-Grade 4
7.444600E-01
Grade 3-vs-Grade 4
7.731200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.237800E-02
Normal-vs-NonDiabetic
1.182630E-01
Diabetic-vs-NonDiabetic
4.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.345430E-01
Normal-vs-NoPancreatitis
1.289610E-01
Pancreatitis-vs-NoPancreatitis
4.04179999999865E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.232820E-01
Normal-vs-N1
1.257970E-01
N0-vs-N1
6.048400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.592800E-01
Normal-vs-TP53-NonMutant
1.417370E-01
TP53-Mutant-vs-TP53-NonMutant
5.853600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
